EC approves Menarini and NewAmsterdam’s obicetrapib therapies

Tuesday, September 22, 2026Salong DebbarmaView original

The EC has granted marketing authorisation to NewAmsterdam Pharma and Menarini Group for Ubeslo and Evlarco.

Read the full article on the original site.